Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
T1h in severe psoriasis-expanded access program (PUCE)
2012-07-20
Registered
1E10 anti-idiotype vaccine, metastatic colon, phase II.
2010-12-03
Registered
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients
2010-12-24
Registered
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II
2010-12-27
Registered
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients
2010-12-28
Registered
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients
2010-12-28
Registered
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II.
2010-12-28
Registered
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III.
2010-12-28
Registered
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin.
2010-12-29
Registered
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.
2010-12-29
Registered
Patients with non small cells lung cancer (NSCLC) and brain metastasis.
2010-12-29
Registered
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.
2010-12-29
Registered
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.
2010-12-29
Registered
14F7 MAb marked with Tc99 Phase II in breast tumors.
2010-12-29
Registered
99mTc-marked 14F7 MaB in metastatic breast, phase II
2008-12-27
Registered
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis
2010-12-27
Registered
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I.
2010-12-27
Registered
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III.
2010-12-27
Registered
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I.
2010-12-17
Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II
2010-12-17
Registered
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform